Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.

Circulation

Volumn 107, Issue 20, 2003, Pages

  Boger, Rainer H ^a   Frystyk, Jan ^a   Ledet, Thomas ^a   Moller, Niels ^a   Flyvbjerg, Allan ^a   Orskov, Hans ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

BLOOD; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG EFFECT; EPIDEMIOLOGY; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; METABOLISM; NOTE; PHYSIOLOGY; RISK; VASCULAR ENDOTHELIUM; VASODILATATION;

CAUSALITY; COMORBIDITY; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; OMEGA-N-METHYLARGININE; RISK; VASODILATION;

MLCS; MLOWN;

EID: 0037506986     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/01.cir.0000074249.75310.65     Document Type: Note

References (0)